Skip to main content

Table 4 Hospitalization, ambulatory, and total costs with estimated attributable costs of overweight and obesity related-diseases

From: The costs of overweight and obesity-related diseases in the Brazilian public health system: cross-sectional study

 

Hospitalization costs*

Hospitalization costs attributable to risk factors(%)

Ambulatory costs* (medical visits, exams, procedures)

Ambulatory costs attributable to risk factors(%)

Total costs* Outpatient and Inpatient care

Total costs attributable to risk factors (%)

 

WOMEN

WOMEN

WOMEN

Obesity

US$ 341,5 million

US$ 46,3 million (13.58%)

US$ 253,5 million

US$ 17,6 million (6.96%)

US$ 595 million

US$ 64 million (10.76%)

Overweight

US$ 262,8 million

US$ 20,2 million (7.69%)

US$ 247,2 million

US$ 15,4 million (6.28%)

US$ 510,1 million

UD$ 35,7 million (7.00%)

Obesity + overweight

US$ 604,3 million

US$ 66,6 million (11.02%)

US$ 500,8 million

US$ 33,1 million (6.62%)

US$ 1,1 billion

US$ 99,7 million (9.02%)

 

MEN

MEN

MEN

Obesity

US$ 435,6 million

US$ 47,2 million (10.86%)

US$ 91,9 million

US$ 12,4 million (13.53%)

US$ 527,6 million

US$ 59,7 million (11.32%)

Overweight

US$ 432,6 million

US$ 49,2 million (11.38%)

US$ 86,5 million

US$ 12,3 million (14.30%)

US$ 519,2 million

US$ 61,6 million (11.87%)

Obesity + overweight

US$ 868,3 million

US$ 96,5 million (11.12%)

US$ 178,5 million

US$ 24,8 million (13.90%)

US$ 1 billion

US$ 121,3 million (11.59%)

 

WOMEN AND MEN

WOMEN AND MEN

WOMEN AND MEN

Obesity

US$ 777,2 million

US$ 93,6 million (12.05%)

US$ 345,5 million

US$ 30 million (8.71%)

US$ 1,1 billion

US$ 123,7 million (11.02%)

Overweight

US$ 695,5 million

US$ 69,4 million (9.99%)

US$ 333,8 million

US$ 27,8 million (8.34%)

US$ 1 billion

US$ 97,3 million (9.45%)

Obesity + overweight

US$ 1,4 billion

US$ 163,1 million (11.08%)

US$ 679,3 million

US$ 57,9 million (8.53%)

US$ 2,1 billion

US$ 221 million (10.27%)

  1. * Three years average (2008 to 2010) of costs related to selected diseases (Table 1).